BioN­Tech ac­quires a for­mer No­var­tis man­u­fac­tur­ing fa­cil­i­ty in Sin­ga­pore

Pfiz­er’s mR­NA vac­cine part­ner BioN­Tech is spread­ing its man­u­fac­tur­ing reach across the globe, with its lat­est foothold in South­east Asia.

BioN­tech an­nounced on Mon­day that its Sin­ga­pore-based af­fil­i­ate, BioN­Tech Phar­ma­ceu­ti­cals Asia Pa­cif­ic Pte. Ltd., had en­tered in­to an agree­ment with No­var­tis to ac­quire a GMP man­u­fac­tur­ing fa­cil­i­ty in the coun­try, with the move de­signed to grow its foot­print in Asia.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.